BackChi Sheng Pharma & Biotech , Ltd Overview

Chi Sheng Pharma & Biotech , Ltd Current Cash

Latest current cash for 4111.TWO: $400M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$397.85M
↓ 5.69% YoYΔ $-24.00M vs prior year quarter

Peer trimmed avg / median

Loading

Chi Sheng Pharma & Biotech , Ltd Current Cash History

Loading

Chi Sheng Pharma & Biotech , Ltd vs. peers: Current Cash Comparison

Loading

Chi Sheng Pharma & Biotech , Ltd Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Chi Sheng Pharma & Biotech , Ltd (4111.TWO) FAQ

As of the most recent data (September 2026), 4111.TWO shows a current cash of $400M. That compares with $420M in the prior-year period — down 5.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 4111.TWO's current cash is now $400M (was $420M) — a 5.7% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Chi Sheng Pharma & Biotech , Ltd is outperforming or lagging.

Tracking 4111.TWO's current cash over time shows whether Chi Sheng Pharma & Biotech , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $400M That compares with $420M in the prior-year period — down 5.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Chi Sheng Pharma & Biotech , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $400M) with ownership activity and broader fundamentals.